Clinical perspectives on medical marijuana (cannabis) for neurologic disorders
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical)
Reference18 articles.
1. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
2. Testing for cannabis in the work-place: a review of the evidence
3. How many drug targets are there?
4. Presynaptic Modulation by Endocannabinoids
5. Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic use of medical Cannabis in neurological diseases: a clinical update;Journal of Neural Transmission;2023-11-28
2. Marijuana use and post-transplant complications and non-compliance in liver transplant patients;The American Journal of the Medical Sciences;2023-02
3. Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: Overview of systematic reviews;Phytotherapy Research;2021-11-29
4. Use of cannabis in patients with multiple sclerosis from Argentina;Multiple Sclerosis and Related Disorders;2021-06
5. Cannabinoid-Based Medicines and Multiple Sclerosis;Cannabinoids and Neuropsychiatric Disorders;2020-12-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3